Soticlestat is a medicine for the treatment of children with Dravet Syndrome and Lennox-Gastaut Syndrome, expected to launch early 2026.

Once awarded this business, our team set out to create the visual foundation for the brand, starting with the color palette. The objective was to create a distinct, ownable color palette that fits within the overall brand identity and aligns with the brand positioning: liberating, nurturing, balanced. This exploration began with an in-depth research into the competitive color space to create a unique, pediatric-friendly palette.

During the palette selection process, the colors were also tested for web-safe accessibility to ensure ADA compliance.